Hemorrhoidal Cream

NDC 0363-0641 · Walgreens

FDA carries 2 listing records for this NDC; the most recent is shown.

Generic nameHemorrhoidal Cream

Dosage formCREAM

RouteTOPICAL

Active ingredient(s)PETROLATUM, GLYCERIN, PRAMOXINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE

Strength144; 150; 2.5; 10 mg/g; mg/g; mg/g; mg/g

Pharmacologic classAdrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]

Marketing categoryOTC MONOGRAPH DRUG

Packages

0363-0641-09 — 1 TUBE in 1 PACKAGE (0363-0641-09) / 25.5 g in 1 TUBE (0363-0641-10)

0363-0641-18 — 1 TUBE in 1 PACKAGE (0363-0641-18) / 51 g in 1 TUBE (0363-0641-19)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0363-0476 — Hemorrhoidal Rectal Suppositories, 0363-0479 — Hemorrhoidal Rectal Suppositories, 0363-0499 — Glycerin suspension, 0363-0512 — Dextromethorphan HBr, Guaifensin, Phenylephrine HCI, 0363-0542 — Guaifenesin, Phenylephrine HCl, 0363-0559 — Acetaminophen, Chlorpheniramine maleate, Phenylephrine HCl, 0363-0582 — Lanolin, Petrolatum, 0363-0603 — acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl, 0363-0623 — Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl, 0363-0640 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 0363-0666 — acetaminophen, dextromethorphan Hbr, Phenylephrine HCl, 0363-0681 — dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, 0363-0712 — Petroleum, 0363-0717 — Phenylephrine hydrochloride, 0363-0721 — Petrolatum, 0363-0731 — Petrolatum, 0363-0740 — Petrolatum Jelly, 0363-0763 — Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl, 0363-0782 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 0363-0841 — Bacitracin Zinc, Neomycin sulfate, Polymyxin B, Pramoxine HCl, +2458 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.